Keratitis Treatment Market

Keratitis treatment sales will strengthen through 2036, anchored by infectious keratitis at 43.0% of the keratitis type segment in 2026. Topical antibiotics lead the treatment segment with a 46.0% share. The market is projected to reach USD 942.5 million in 2026 and USD 1.72 billion by 2036, creating an incremental opportunity of USD 777.5 million.